-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BkmXbNrB7hGtbe9I12Dpfjr6Ad7jRKNJXusLCTzo8ck3R6RQbqVbLNEJlC8V9tVX m0jr6LexYEj+2Z7KcPTrag== 0001209191-07-059369.txt : 20071023 0001209191-07-059369.hdr.sgml : 20071023 20071023155948 ACCESSION NUMBER: 0001209191-07-059369 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071022 FILED AS OF DATE: 20071023 DATE AS OF CHANGE: 20071023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adams Respiratory Therapeutics, Inc. CENTRAL INDEX KEY: 0001319439 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 752725552 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 4 MILL RIDGE LANE CITY: CHESTER STATE: NJ ZIP: 07930 BUSINESS PHONE: (908) 879-1400 MAIL ADDRESS: STREET 1: 4 MILL RIDGE LANE CITY: CHESTER STATE: NJ ZIP: 07930 FORMER COMPANY: FORMER CONFORMED NAME: Adams Laboratories, Inc. DATE OF NAME CHANGE: 20050302 FORMER COMPANY: FORMER CONFORMED NAME: Adams Respiratory Therapeutics, Inc. DATE OF NAME CHANGE: 20050301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thievon John CENTRAL INDEX KEY: 0001331752 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51445 FILM NUMBER: 071185719 BUSINESS ADDRESS: BUSINESS PHONE: 908-879-1400 MAIL ADDRESS: STREET 1: 425 MAIN STREET CITY: CHESTER STATE: NJ ZIP: 07930 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2007-10-22 0 0001319439 Adams Respiratory Therapeutics, Inc. ARXT 0001331752 Thievon John 14801 SOVEREIGN ROAD FORT WORTH TX 76155 0 1 0 0 EVP, Sales & Corp. Accts. Common Stock 2007-10-22 4 M 0 3159 0.40 A 3159 D Common Stock 2007-10-22 4 S 0 3159 38.67 D 0 D Stock Option (Right to Buy) 0.40 2007-10-22 4 M 0 3159 0.00 D 2013-10-21 Common Stock 3159 3159 D The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2007. The options vest in five equal annual installments, beginning on October 21, 2004. /s/ Brad Cole, Attorney-in-fact 2007-10-23 -----END PRIVACY-ENHANCED MESSAGE-----